Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medical modeling and simulation software company Simulations Plus has been awarded a grant from the Food and Drug Administration through a joint proposal with the University of Bath’s Department of Life Sciences.
Project will focus on the development of a modeling simulation framework to support an assessment of bioequivalence for locally-acting drugs in the gastrointestinal tract Simulations Plus, Inc.
Simulations Plus, Inc. (NASDAQ:NASDAQ:SLP) Q4 2022 Earnings Conference Call October 26, 2022 5:00 PM ET Company Participants Brian Siegel – Hayden IR Shawn O’Connor – Chief Executive...
Conference call to be on Wednesday, October 26, 2022, at 5:00 PM ETLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2022, the period ended August 31, 2022, after the close of the financial...
/PRNewswire/ -- The "Global Biosimulation Market Size, Share & Trends Analysis Report by Product (Software, Services), by Application (Drug Development, Drug...